Abbott | ABT - الربح الإجمالي على المبيعات

سعر السهم
91.88
التغيير اليومي
-1.98 -2.11%
شهريا
-9.82%
سنويا
-29.73%
Q2 التوقعات
89.18




الربح الإجمالي على المبيعات تغيير تاريخ
Abbott USD 5.86B 675M 2026-03
Agilent USD 946M 44M 2025-12
AtriCure USD 105.34M 4M 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Bio-Rad Laboratories USD 343.4M 1.9M 2025-09
Boston Scientific USD 3.61B 64M 2026-03
Cooper Companies USD 695.2M 44.4M 2025-12
Danaher USD 3.59B 375M 2026-03
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 535.95M 49.28M 2025-12
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Smith & Nephew USD 2.09B 117M 2025-12
Solventum Corp USD 1.03B 108M 2025-12
Stryker USD 4.49B 633M 2025-12
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Terumo JPY 153.19B 6.2B 2025-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12